Answers are grounded in this paper and cite their sources.
Inflammatory bowel disease (IBD) and allergic diseases share genetic liability, but subtype and regional patterns remain uncertain. We analysed European-ancestry summary statistics for Crohn’s disease (CD), ulcerative colitis (UC), combined IBD, and four allergic phenotypes using genetic correlation, Mendelian randomization (MR), Causal Analysis Using Summary Effect estimates (CAUSE), targeted colocalization, fine-mapping, and gene and functional follow-up; UK Biobank analyses served as cross-dataset consistency checks. Genetic sharing was detected more consistently for CD than for UC, without a formal subtype difference. Reference inverse-variance-weighted MR associations of genetically predicted CD log odds with atopic dermatitis, allergic rhinitis, and allergic conjunctivitis passed within-family false-discovery-rate correction; CD–asthma did not, whereas secondary discovery-only combined-IBD associations passed correction for all four outcomes. Three CAUSE comparisons had nominal model-comparison P values, but none survived within-family correction. Regional architectures were heterogeneous: targeted 5q31 CD–asthma colocalization support was high but specification dependent; 2q12 remained unresolved, and 17q12–21 supported distinct IBD and asthma signals. Regulatory and functional follow-up did not establish a stable target-specific mechanism, and SLC22A5 remained a 5q31 regional candidate. Resolving these signals requires ancestry- and linkage-disequilibrium (LD)-matched fine-mapping with estimable regulatory data and direct perturbation in disease-relevant models.
No takes yet. Share an insight, caveat, or question.
Yin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: